United Kingdom· GB-APID-41489911000001104
Upstaza 280 giga vector genomes/0.5ml solution for infusion vials
A eladocagene exuparvovec product containing eladocagene exuparvovec, registered in United Kingdom by PTC Therapeutics Ltd. The same ATC class is registered in 10 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Eladocagene exuparvovec is registered in 10 of 19 countries.
Countries holding a registration under ATC A16AB26 (eladocagene exuparvovec), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Eladocagene exuparvovec · ATC A16AB26
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Eladocagene exuparvovec
- Manufacturer
- PTC Therapeutics Ltd
- Country
- United Kingdom (GB)
- ATC code
- A16AB26
- ATC class
- Eladocagene exuparvovec
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5391528830978
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Eladocagene exuparvovec in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesKEBILIDIPTC Therapeutics, Inc.
- CzechiaUPSTAZAPTC Therapeutics International Limited, Dublin 2
- SpainUPSTAZA 2,8 × 10E11 GENOMAS VECTORIALES (VG)/0,5 ML PARA SOLUCION PARA PERFUSIONPtc Therapeutics International Limited
- FinlandUpstazaPTC Therapeutics International limited
- FranceUPSTAZA 2,8 x 100 000 000 000 génomes de vecteur (vg)/0,5 mL, solution pour perfusionPTC THERAPEUTICS INTERNATIONAL (IRLANDE)
- BelgiumUpstaza 2.8 10*11 vg/0.5 mlPTC Therapeutics International
- IcelandUpstazaPTC Therapeutics International Limited*
- NetherlandsUpstaza 2,8 x 10^11 vg/0.5 ml, oplossing voor infusiePTC Therapeutics International Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Upstaza
- Liechtenstein · Upstaza
- Norway · Upstaza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9176873e-8884-45d1-8bbf-9fcd49e551ae GET /v1/drugs/9176873e-8884-45d1-8bbf-9fcd49e551ae?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "41489911000001104",
"desc": "Upstaza 280 giga vector genomes/0.5ml solution for infusion vials (PTC Therapeutics Ltd)",
"form": "Solution for infusion",
"vpid": "41495911000001102",
"source": "dmd",
"vtm_id": "41490211000001102",
"strength": "560 giga vector genome",
"substance": "Eladocagene exuparvovec",
"ingredient": "Eladocagene exuparvovec",
"supplier_code": "32897511000001106"
}See everything about eladocagene exuparvovec.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.